{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:13:31Z","timestamp":1789665211317,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.lpm.2008.02.010","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T12:34:30Z","timestamp":1209472470000},"page":"1069-1072","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Automesure de l\u2019INR\u00a0: pour quels patients\u00a0?"],"prefix":"10.1016","volume":"37","author":[{"given":"G\u00e9rard","family":"Helft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2008.02.010_bib1","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.287.13.1690","article-title":"Association betwwen CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy","volume":"287","author":"Higashi","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2008.02.010_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1018778914477","article-title":"Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management","volume":"9","author":"Samsa","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.lpm.2008.02.010_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2796.1997.tb00023.x","article-title":"Major haemorrhagic complications duting oral anticiagulant therapy in a Danish population-based cohort","volume":"242","author":"Steffensen","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.lpm.2008.02.010_bib4","doi-asserted-by":"crossref","unstructured":"SPORTIF Executive Steering Committee for the SPORTIF V Investigators. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. JAMA. 2005; 293: 690-8.","DOI":"10.1001\/jama.293.6.690"},{"key":"10.1016\/j.lpm.2008.02.010_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/j.1875-9114.1989.tb04128.x","article-title":"The safety and effectiveness of long-term warfarin-therapy in an anticoagulation clinic","volume":"9","author":"Bussey","year":"1989","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.lpm.2008.02.010_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0037-1614036","article-title":"A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for theomboplastin","volume":"84","author":"van den Besselaar","year":"2000","journal-title":"Thromb Haemost"},{"issue":"230 Suppl","key":"10.1016\/j.lpm.2008.02.010_bib7","article-title":"Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy","volume":"17","author":"Horstkotte","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2008.02.010_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(00)02470-3","article-title":"Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomized cross-over comparison","volume":"356","author":"Cromheecke","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2008.02.010_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2003.11.008","article-title":"Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation","volume":"99","author":"Ansell","year":"2005","journal-title":"Int Journal Cardiol"},{"key":"10.1016\/j.lpm.2008.02.010_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self-monitoring of oral anticoagulation: a systematic review and meta-analysis","volume":"367","author":"Heneghan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2008.02.010_bib11","first-page":"1462","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549820800211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549820800211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T17:00:16Z","timestamp":1557507616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549820800211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S075549820800211X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2008.02.010","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}